MarginsXMarginsX
Home › Markets › Health Care › TNDM

Tandem Diabetes Care Inc. (TNDM)

TNDM trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$18.48
-7.92% on the day
Market cap
$1.3B
Small cap
Revenue · 2025
$1.0B
+7.9% on 2024
Net income · 2025
-$204.7M
-20.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/0001438133-26-000010-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerTNDM on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2013
SEC CIK0001438133
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.0B
Net income-$204.7M
Operating income-$187.3M
Net margin-20.2%
Operating margin-18.5%
Revenue growth+7.9%
Cash$90.6M
Total assets$881.1M
P/E (computed)Net income was not positive
P/S (computed)1.3×

Warning signs

Cash runway
59.8 months
$72.8M cash at September 30, 2026
Share count, 1 year
+2.9%
2025-11-04 to 2026-11-02 · +7.0% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$4K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$72.8M cash; operating cash flow -$3.7M a quarter.Report 2026-09-30
Shares outstanding69,793,846 (2026-11-02); 67,802,359 a year earlier; 65,209,703 three years earlier.Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, San Diego, California, United StatesPCAOB Form AP 2026-03-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $4K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$283.7M-$7.1M-$819K$72.8M$603.4M$1.1B10-Q 2026-11-05
Q2 2026
2026-06-30
$254.6M-$21.2M-$34.6M$62.8M$602.6M$1.0B10-Q 2026-08-06
Q1 2026
2026-03-31
$247.2M-$20.4M$11.1M$179.3M$601.8M$1.0B10-Q 2026-05-07
Q4 2025
2025-12-31
$290.4M-$589K$9.8M$90.6M$310.0M$1.0B10-K 2026-02-19
Q3 2025
2025-09-30
$249.3M-$21.2M$8.3M$91.9M$309.6M$1.0B10-Q 2026-11-05
Q2 2025
2025-06-30
$240.7M-$52.4M-$9.5M$64.1M$309.1M$1.0B10-Q 2026-08-06
Q1 2025
2025-03-31
$234.4M-$130.6M-$18.3M$53.6M$308.7M$983.0M10-Q 2026-05-07
Q4 2024
2024-12-31
$282.6M$755K$10.7M$69.2M$348.9M$940.2M10-K 2026-02-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
424B5 PROSPECTUS 08-2018
424B52018-08-03
Latest annual report10-K2026-02-19
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-13
Latest proxyDEFA14A2026-04-07

Source: SEC EDGAR submissions feed, 1,004 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+18.7%
1 month+20.5%
3 months-13.2%
Year to date-8.7%
1 year+14.5%
From 52-week high-29.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
NVCRNovoCure Limited$11.30-4.48%$1.3B
PRCTPROCEPT BioRobotics Corporation$23.54-1.09%$1.4B
DRTSAlpha Tau Medical Ltd.$11.97-10.54%$1.1B
IARTIntegra LifeSciences Holdings Corporation$13.98-2.92%$1.1B
IRMDiRadimed Corporation$84.84-0.60%$1.1B
SGPSpyGlass Pharma Inc.$32.24-1.95%$1.1B
SIBNSI-BONE Inc.$23.41-0.13%$1.1B
ATECAlphatec Holdings Inc.$6.78-4.10%$1.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier